Hemorrhoid Drugs Market Segmentation:
Treatment Type Segment Analysis
The non-surgical segment is anticipated to garner the largest share of 68.5% by the end of 2035. The segment’s exposure is primarily attributed to its provision of cost-effective, lower-risk, and less invasive alternatives to surgery, especially for early-stage hemorrhoids. According to an article published by Emedicine Medscape in May 2022, nonoperative techniques, including the rubber band ligation, effectively produce recurrence rates ranging between 30% to 50% within 5 to 10 years. However, these particular recurrences are usually addressed with suitable nonoperative treatments, thereby suitable for uplifting the overall segment.
Severity Segment Analysis
The Grade I and II segment is projected to account for the second-highest share during the predicted period. The segment’s growth is highly driven by its suitability and prevalence for pharmacological management. These particular stages are readily characterized by mild prolapse or painless bleeding that spontaneously diminishes, thereby displaying the majority of diagnosed incidences. This develops a recurring and substantial patient pool, initially managed with conventional treatment options. Besides, both prescription topical medication and over-the-counter (OTC) medications, including suppositories, ointments, and creams with corticosteroids and astringents, are considered the first-line therapy.
Distribution Channel Segment Analysis
The retail and hospital pharmacies segment is expected to constitute the third-largest share by the end of the forecast duration. The segment’s development is fueled by its vital role as the primary access point for both prescribed medications and immediate OTC relief. For the massive OTC field, retail pharmacies provide the option, immediate availability, and convenience for pharmacist consultation, which is essential for self-treating patients. Meanwhile, hospital pharmacies dispense medications that are readily prescribed following surgeries, procedures, and physician consultations, thus capturing the high-value prescription segment.
Our in-depth analysis of the global market includes the following segments:
|
Segment |
Subsegments |
|
Treatment Type |
|
|
Severity |
|
|
Distribution Channel |
|
|
Drug Class |
|
|
Product Type |
|
|
Formulation |
|
